IMP3 / Insulin like growth factor 2 mRNA binding protein 3 Antibody from BIORBYT LTD.
Search, find, compare suppliers for anti-IMP3 / Insulin like growth factor 2 mRNA binding protein 3 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | IMP3 / Insulin like growth factor 2 mRNA binding protein 3 |
| Clone | IMP3/8934R |
| Host Species | Recombinant Rabbit |
| Reactive Species | human |
| Isotype | IgG, kappa |
| Format | unconjugated |
| Size | 20 ug |
| Concentration | n/a |
| Applications | IHC-P |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Imp3, also known as BRMS2, C15orf12 or MRPS4, is a 184 amino acid protein that contains one S4 RNA-binding domain and is the mammalian homolog of the yeast Imp3 protein. Localized to the nucleus, Imp3 exists as a component of a heterotrimeric complex consisting of MPP10, Imp3 and Imp4 and, in this complex, plays a key role in early cleavage events during pre-18S ribosomal processing. The gene encoding Imp3 maps to human chromosome 15, which houses over 700 genes and comprises nearly 3% of the human genome. Angelman syndrome, Prader-Willi syndrome, Tay-Sachs disease and Marfan syndrome are all associated with defects in chromosome 15-localized genes. |
| Immunogen | A recombinant fragment of human protein was used as the immunogen for the IMP3 antibody. |
| Other Names | n/a |
| Gene, Accession # | UniProt: Q9NV31 |
| Catalog # | orb1825401 |
| Price | $405 |
| Order / More Info | IMP3 / Insulin like growth factor 2 mRNA binding protein 3 Antibody from BIORBYT LTD. |
| Product Specific References | n/a |
BIORBYT LTD.
BIORBYT LTD.
7 Signet Court
Swann Road
Cambridge, CB5 8LA U.K.
P: +44 (0)1223 859 353
F: +44(0)1223 280 240
info@biorbyt.com
http://www.biorbyt.com
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558
Profile of BIORBYT LTD.
Return to Antibodies